Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Diabetes mellitus Patients.

Bücher zum Thema „Diabetes mellitus Patients“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Bücher für die Forschung zum Thema "Diabetes mellitus Patients" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Bücher für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Langer, Anatoly. Silent myocardial ischemia in asymptomatic patients with diabetes mellitus. Ottawa: National Library of Canada, 1990.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Tattersall, Robert. Diabetes, a practical guide for patients on insulin. 2. Aufl. Edinburgh: Churchill Livingstone, 1985.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Davis, Roger E. A. Studies on blood platelet subpopulations in relation to patients with diabetes mellitus. [s.l.]: typescript, 1988.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Kazantzaki, I. Anthropometric measurements in coronary heart disease patients with or without diabetes mellitus. London: University of Surrey Roehampton, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Diabetes in hospital: A practical approach for all healthcare professionals. Chichester, West Sussex, UK: J. Wiley & Sons, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Type 2 diabetes: Social and scientific origins, medical complications and implications for patients and others. Jefferson, N.C: McFarland & Co., 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Kagan, Andrew. Type 2 diabetes: Social and scientific origins, medical complications and implications for patients and others. Jefferson, N.C: McFarland & Co., 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Glycemic control in the hospitalized patient: A comprehensive clinical guide. New York: Springer, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

If your child has diabetes: An answer book for parents. New York, NY: Perigee Books, 1990.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

The ten keys to helping your child grow up with diabetes. Alexandria, Va: American Diabetes Assoc., 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Malmberg, Klas. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. London: BMJ Publishing, 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Parenting a diabetic child: A practical, empathetic guide to help you and your child live with diabetes. Los Angeles: Lowell House, 1993.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Loring, Gloria. Parenting a diabetic child: A practical, empathetic guide to help you and your child live with diabetes. Los Angeles: Lowell House, 1991.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

1947-, Anderson Barbara J., Weissberg-Benchell Jill und American Diabetes Association, Hrsg. Transitions in care: A guide on the challenges of type 1 diabetes in the young adult period for patients, their families, and health care providers. Alexandria, Va: American Diabetes Association, 2009.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

International Conference on the Western Pacific Diabetes Information Network (WPDIN) (1st 2000 Kyoto, Japan). e-Health for diabetes in the Western Pacific: Proceedings of the 1st International Conference on the Western Pacific Diabetes Information Network (WPDIN) : held in Kyoto on 14 November 2000. Herausgegeben von Akazawa Yoshiharu, Aoki Norihiko 1938- und LaPorte Ronald. Amsterdam: Elsevier, 2000.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

Mol, Annemarie. The logic of care: Health and the problem of patient choice. Abingdon, Oxon: Routledge, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Corabian, Paula. Patient diabetes education in the management of adult type 2 diabetes. Edmonton: Alberta Heritage Foundation for Medical Research, 2001.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

Philis-Tsimikas, Athena. Scripps Whittier Diabetes Institute guide to patient management & prevention of diabetes. Boston: Jones and Bartlett Publishers, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

B, Travis Luther, Hrsg. An instructional aid on insulin-dependent diabetes mellitus. 9. Aufl. Austin, Tex: Century Business Communications, Inc., 1992.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Whettem, Erica. Diabetes. Harlow, England: Pearson, 2012.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

D, Hill R., und Kirby Michael MRCP, Hrsg. Shared care for diabetes. Oxford: Isis Medical Media, 1997.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Stephanie, Decker, und Scripps Whittier Diabetes Institute, Hrsg. Scripps Whittier Diabetes Institute guide to patient management & prevention. Boston: Jones and Bartlett Publishers, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Inc, ebrary, Hrsg. What nurses know-- diabetes. New York: Demos Health, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

The logic of care: Health and the problem of patient choice. Abingdon, Oxon: Routledge, 2008.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

Philis-Tsimikas, Athena. The Scripps Whittier Diabetes Institute guide to patient management and prevention. Boston: Jones and Bartlett Publishers, 2010.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

M, Brett Elise, Hrsg. Nutritional strategies for the diabetic/prediabetic patient. Boca Raton: CRC Press/Taylor & Francis Group, 2006.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Scherbaum, W. A. Fachinformationssystem Diabetes mellitus: Aufbau eines Fachinformationssystems zum Diabetes mellitus im Internet : Projektbericht und Ergebnisse der Online-Befragung und der Telefonumfrage "Medien und Gesundheit". Baden-Baden: Nomos Verlagsgesellschaft, 2004.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Gnudi, Luigi, Giorgio Gentile und Piero Ruggenenti. The patient with diabetes mellitus. Herausgegeben von Giuseppe Remuzzi. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199592548.003.0149_update_001.

Der volle Inhalt der Quelle
Annotation:
About one third of patients with type 1 diabetes develop diabetic nephropathy long-term (usually not before at least 10 years of diabetes), though this proportion is falling as standards of care have risen. Nephropathy is strongly associated with other microvascular complications of diabetes, so that some degree of retinopathy is to be expected, and evidence of neuropathy is common. Patients with type 2 diabetes are equally susceptible, but this is an older group in which vascular disease and other pathologies are also more likely. The rise in type 2 diabetes accounts for diabetes being the most common recorded cause of end stage renal disease (ESRD) in the developed world.Diabetic nephropathy is characterized by a progression through hyperfiltration, microalbuminuria, hypertension, overt proteinuria, nephrotic syndrome, loss of GFR, to ESRD. Risk factors for developing it include genetic factors (though no major single gene effects have been identified), and quality of glycaemic control.The risk of progression can at early stages be reduced by improved glycaemic control, and control of hypertension also slows progression. However angiotensin converting enzyme inhibitors or receptor blockers (ACEi, ARB) are the standard of care for patients with microalbuminuria or overt proteinuria, as they have been shown to reduce the risk of renal endpoints. Combination therapy with both ACEi and ARB together has been associated with a high risk of AKI, hyperkalaemia and other adverse effects so is not generally recommended. Other promising agents in combination are under investigation but none adequately proven at this stage.Patients who reach ESRD have reduced survival on all modalities compared to age-matched patients with other diagnoses. Best rehabilitation and survival for those who are suitable is through renal transplantation, though combined pancreas-renal transplantation may offer still better outcomes for selected patients.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Ahmad, Shamim I. Diabetes: A Comprehensive Treatise for Patients and Care Givers. Taylor & Francis Group, 2015.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

Islet transplantation in patients with type 1 diabetes mellitus. [Rockville, MD.]: Agency for Healthcare Research and Quality, 2004.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Cuocolo, Alberto, und Emilia Zampella. Role of Imaging in Diabetes Mellitus. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0018.

Der volle Inhalt der Quelle
Annotation:
Although there has been a marked decline in mortality due to coronary artery disease (CAD) in the overall population in the past three decades, reducing CAD mortality in patients with diabetes mellitus (DM) has proven exceptionally difficult. Several epidemiological studies have shown that DM is associated with a marked increase in the risk of CAD. The symptoms are not a reliable means of identifying patients at higher risk considering that angina is threefold less common in DM than in non-DM. Noninvasive cardiac imaging, such as echocardiography, nuclear cardiology, computed tomography, and magnetic resonance imaging, can provide insight into different aspects of the disease process, from imaging at the cellular level to microvascular and endothelial dysfunction, autonomic neuropathy, coronary atherosclerosis, and interstitial fibrosis with scar formation. In particular, stress myocardial perfusion imaging has taken a central role in the diagnosis, evaluation, and management of CAD in DM patients.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

Diabetes: Caring for Patients in the Community. Churchill Livingstone, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

S, McDowell Joan R., und Gordon Derek M. D, Hrsg. Diabetes: Caring for patients in the community. New York: Churchill Livingstone, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

(Foreword), Ian Botham, Hrsg. Riding the Diabetes Rollercoaster: A New Approach for Health Professional, Patients and Carers. Radcliffe Publishing, 2007.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Almedawar, Mohamad M., Richard C. Siow und Henning Morawietz. MicroRNAs as novel biomarkers in depression, diabetes, and cardiovascular diseases. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198789284.003.0003.

Der volle Inhalt der Quelle
Annotation:
Diabetic, depressive, and cardiovascular disorders are leading causes of morbidity. In diabetics, symptoms of depression are associated with increased clinical complications. Diabetes mellitus is a major risk factor of cardiovascular diseases (CVDs). The vascular depression hypothesis suggests that CVD can increase the risk of depression or exacerbate depression-related conditions. Several studies found a strong correlation between depression and pre-existing vascular disease and vice versa. Recent studies implicate microvascular dysfunction in the pathophysiology of depression and CVD. In addition, microRNAs are potent regulators of gene expression in physiological and pathophysiological processes affecting the microcirculation. We propose an interaction between diabetes mellitus, depression, and CVD involving changes in microcirculation and microRNA expression. Hence, studies are warranted to develop novel microRNA therapeutics and biomarkers to identify diabetic patients at increased risk of developing clinical complications of depression.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Association, American Diabetes, Patti B. Geil und Laura Hieronymus. 101 Tips for Raising Healthy Kids with Diabetes. American Diabetes Association, 2006.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Chapple, Susan. An investigation into the profile of peripheral sensory neuropathy in patients diagnosed with diabetes mellitus. 1999.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

1947-, Anderson Barbara J., Rubin Richard R und American Diabetes Association, Hrsg. Practical psychology for diabetes clinicians: How to deal with the key behavioral issues faced by patients and health-care teams. Alexandria, VA: American Diabetes Association, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Scheiner, Gary, Karen M. Bolderman, American Diabetes Association Staff und Nicholas B. Argento. Putting Your Patients on the Pump. American Diabetes Association, 2013.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Putting Your Patients on the Pump. American Diabetes Association, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Feinglos, Mark N., Lillian F. Lien und Mary E. Cox. Glycemic Control in the Hospitalized Patient: A Comprehensive Clinical Guide. Springer, 2011.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Barbara J., Ph.D. Anderson (Editor) und Richard R. Rubin (Editor), Hrsg. Practical Psychology for Diabetes Clinicians: How to Deal With the Key Behavioral Issues Faced by Patients and Health-Care Teams (Practical Approaches in Diabetes Care). American Diabetes Association, 1996.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Pediatric Diabetes: Health Care Reference and Client Education Handouts. American Dietetic Assoication, 2006.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

Elliott, Joanne. If Your Child Has Diabetes: An Answer Book for Parents. Cleveland Clinic Press, 2005.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Rapaport, Wendy Satin. Approaches to Behavior: Changing the Dynamic Between Patients and Professionals in Diabetes Education. American Diabetes Association, 2014.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Differential fuel utilization and energy expenditure in patients with cystic fibrosis with or without cystic fibrosis related diabetes mellitus. 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Differential fuel utilization and energy expenditure in patients with cystic fibrosis with or without cystic fibrosis related diabetes mellitus. 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

Differential fuel utilization and energy expenditure in patients with cystic fibrosis with or without cystic fibrosis related diabetes mellitus. 1995.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

Herrington, William G., Aron Chakera und Christopher A. O’Callaghan. Diabetic renal disease. Herausgegeben von Patrick Davey und David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0164.

Der volle Inhalt der Quelle
Annotation:
Diabetic nephropathy is kidney damage occurring as a result of diabetes mellitus. Overt diabetic nephropathy is defined as proteinuria greater than 0.5 g/day. Diabetic nephropathy has a complicated pathogenesis including glomerular hypertension with hyperfiltration and advanced glycation end products. Poor glycaemic control is associated with progression to microalbuminuria and overt diabetic nephropathy. The lifetime risk is fairly equivalent for type 1 and type 2 diabetes mellitus. Early disease is usually asymptomatic. Hyperglycaemia causes an osmotic diuresis and, thus, diabetes can present with polyuria. Hypertension develops with microalbuminuria; oedema indicates abnormal sodium and water retention and, occasionally, the development of nephrotic syndrome. Patients with diabetes, perhaps due to accompanying cardiac disease, are particularly susceptible to fluid overload and uraemic symptoms. End-stage renal disease can occur as early as when the estimated glomerular filtration rate is 15 ml/min 1.73 m−2.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Guo, Bing. Islet cell transplantation for the treatment of non-uremic type 1 diabetic patients with severe hypoglycemia (HTA). Alberta Heritage Foundation for Medical Research, 2003.

Den vollen Inhalt der Quelle finden
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!

Zur Bibliographie